CIG
ABBV icon

Cairn Investment Group’s AbbVie ABBV Stock Holding History

Cairn Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Hold
973
– – 0.11% 63
2025
Q4 		$222K Hold
973
– – 0.11% 65
2025
Q3 		$225K Buy
+973
New +$198K 0.1% 69
2023
Q1 		– Sell
-2,482
Closed -$401K – 65
2022
Q4 		$401K Buy
2,482
+346
+16% +$53.1K 0.3% 52
2022
Q3 		$287K Sell
2,136
-259
-11% -$37.2K 0.23% 60
2022
Q2 		$367K Buy
+2,395
New +$366K 0.29% 60

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cairn Investment Group's ABBV Position: Q1 2026 in Review

Cairn Investment Group held its AbbVie (ABBV) position steady in Q1 2026 at 973 shares worth $212K. The position accounts for 0.11% of the portfolio, ranked #63.

Cairn Investment Group first reported a position in ABBV in Q2 2022 and has held it in 6 quarters since. The position peaked at $401K in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cairn Investment Group held 973 shares of AbbVie worth $212K as of Q1 2026.
  • Cairn Investment Group left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.11% of Cairn Investment Group's portfolio in Q1 2026, its #63 holding.
  • Cairn Investment Group first reported a position in AbbVie in Q2 2022 and has held it in 6 quarters since.
  • Cairn Investment Group's AbbVie position peaked at $401K in Q4 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cairn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.